Skip to content

Scholar Rock SRRK Long-Term Debt

Long-Term Debt at other companies

Biogen logo
BiogenBIIB
$6.29B+38.2%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$149.38M
Cytokinetics logo
CytokineticsCYTK
$247.21M+169%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$98.34M-8.9%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$2.44B-1.8%
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Reported directly by Scholar Rock in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's long-term debt?
Scholar Rock (SRRK) reported long-term debt of $196.61M in Q1 2026.
How has Scholar Rock's long-term debt changed year-over-year?
Scholar Rock's long-term debt increased by 295.3% year-over-year, from $49.74M to $196.61M.
What is the long-term trend for Scholar Rock's long-term debt?
Over 5 years (2020 to 2025), Scholar Rock's long-term debt has grown at a 32.2% compound annual growth rate (CAGR), from $24.68M to $99.71M.
What does long-term debt mean?
Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.